Universidade de Campinas, Faculdade de Ciências Médicas, Programa de Pós-Graduação, Gastrocentro, Campinas, SP, Brasil.
Universidade Estadual de Campinas, Gastrocentro, Campinas, SP, Brasil.
Arq Gastroenterol. 2022 Jul-Sep;59(3):421-427. doi: 10.1590/S0004-2803.20220300075.
Endoscopic treatment of precancerous lesions and early gastric cancer has been widely accepted in recent years. Endoscopic submucosal dissection (ESD), following established indication criteria, can lead to cure of the disease in more than 90% of cases.
This study aimed to analyze the use of ESD in patients with early gastric cancer and precancerous lesions, as well as the results of the procedure, its complications and effectiveness in controlling the disease.
This is a retrospective cohort study composed of 41 patients aged from 53 to 87 years (mean age: 65 years; 58.53% male) who were analyzed from 2008 to 2019. The variables collected from the medical records were: comorbidities, classification of the lesion regarding resection criteria, type of resection, histology, degree of invasion, resection margin, complications, disease recurrence. Statistical analysis was performed using the Kruskal-Wallis test, the McNemar's test, and the Mann-Whitney test, with 5% statistical significance (P<0.05).
The most frequent site of the lesion was the gastric antrum and the predominant presentation by the Japanese or Paris classification was the one with depressed components in 56.09%. Adenocarcinoma occurred in 75.6% of the biopsies, and the remainder were adenomas without neoplasia. En-bloc resection occurred in 97.57% of cases, and compromise of the safety margin occurred in one patient. The main pre-existing comorbidity was liver cirrhosis in 29.26% of cases. There was a significant increase in post- ESD adenocarcinoma compared to pre-resection diagnosis. The mean follow-up time was 38.4 months, with one recurrence (2.43%) and two metachronous lesions (4.87%). Complications during and after the procedure occurred in three patients (7.31%), being due to bleeding (two cases) and perforation (one case). There was one death due to a cardiac event not directly related to the procedure.
Endoscopic submucosal dissection proved to be a safe procedure, with a low complication and recurrence rate. Its recommendation must occur within the established criteria; however, it can be indicated for patients outside the criteria, if there is a high risk for surgical treatment.
近年来,内镜下治疗癌前病变和早期胃癌已被广泛接受。在符合既定适应证标准的情况下,内镜黏膜下剥离术(ESD)可使超过 90%的病例获得治愈。
本研究旨在分析 ESD 在早期胃癌和癌前病变患者中的应用,并探讨该手术的疗效、并发症及其对疾病控制的效果。
这是一项回顾性队列研究,纳入了 2008 年至 2019 年期间的 41 例年龄在 53 岁至 87 岁之间(平均年龄:65 岁;58.53%为男性)的患者。从病历中收集的变量包括:合并症、病变切除标准分类、切除类型、组织学、浸润程度、切缘、并发症、疾病复发。采用 Kruskal-Wallis 检验、McNemar 检验和 Mann-Whitney 检验进行统计学分析,以 5%为显著性水平(P<0.05)。
病变最常见的部位是胃窦,根据日本或巴黎分类法,以凹陷型为主的病变占 56.09%。活检中腺癌发生率为 75.6%,其余为无肿瘤性的腺瘤。整块切除率为 97.57%,1 例切缘不安全。最常见的合并症是 29.26%的患者存在肝硬化。ESD 后腺癌的检出率明显高于术前诊断。平均随访时间为 38.4 个月,有 1 例复发(2.43%)和 2 例同时性病变(4.87%)。3 例患者(7.31%)在术中及术后出现并发症,其中 2 例为出血,1 例为穿孔。有 1 例死亡是由于与手术无关的心脏事件。
内镜黏膜下剥离术是一种安全的手术方法,并发症和复发率较低。该方法的推荐必须符合既定标准,但如果手术风险较高,也可以对超出标准的患者进行治疗。